Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Levin MJ, Anderson JP, Seage GR 3rd, Williams PL; PACTG/IMPAACT 219C Team..

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):182-91. doi: 10.1097/QAI.0b013e31819550a4.

2.

Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.

Tangsinmankong N, Kamchaisatian W, Lujan-Zilbermann J, Brown CL, Sleasman JW, Emmanuel PJ.

J Allergy Clin Immunol. 2004 Apr;113(4):742-6.

PMID:
15100682
3.

Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study.

Hung CC, Hsiao CF, Wang JL, Chen MY, Hsieh SM, Sheng WH, Chang SC.

Int J STD AIDS. 2005 Oct;16(10):673-6.

PMID:
16212714
4.

Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.

Weinberg A, Wiznia AA, LaFleur BJ, Shah S, Levin MJ.

J Infect Dis. 2004 Jul 15;190(2):267-70. Epub 2004 Jun 9.

PMID:
15216460
5.

Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.

Wood SM, Shah SS, Steenhoff AP, Rutstein RM.

Pediatrics. 2008 Jan;121(1):e150-6. Epub 2007 Dec 17.

PMID:
18086820
6.

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Ylitalo N, Brogly S, Hughes MD, Nachman S, Dankner W, Van Dyke R, Seage GR 3rd; Pediatric AIDS Clincial Trials Group Protocol 219C Team..

Arch Pediatr Adolesc Med. 2006 Aug;160(8):778-87.

PMID:
16894075
7.

Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children.

Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirisanthana V.

Pediatr Infect Dis J. 2006 Jan;25(1):53-8.

8.

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

Gona P, Van Dyke RB, Williams PL, Dankner WM, Chernoff MC, Nachman SA, Seage GR 3rd.

JAMA. 2006 Jul 19;296(3):292-300.

PMID:
16849662
9.

Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis.

Jansen K, Haastert B, Michalik C, Guignard A, Esser S, Dupke S, Plettenberg A, Skaletz-Rorowski A, Brockmeyer NH.

BMC Infect Dis. 2013 Aug 10;13:372. doi: 10.1186/1471-2334-13-372.

10.

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.

Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team..

Clin Infect Dis. 2008 Feb 15;46(4):507-15. doi: 10.1086/526524.

PMID:
18199042
11.

Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy.

Gkentzi D, Tebruegge M, Tudor-Williams G, Walters S, Lyall H, Sharland M, Doerholt K.

Pediatr Infect Dis J. 2014 Sep;33(9):953-8. doi: 10.1097/INF.0000000000000331.

PMID:
24618936
12.

Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru.

Wang ME, Castillo ME, Montano SM, Zunt JR.

Pediatr Infect Dis J. 2009 Oct;28(10):900-3. doi: 10.1097/INF.0b013e3181a4b7fa.

13.

Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.

Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C, Rey D, Daneluzzi V, Ferret S, Lascaux AS, Hanslik T, Costagliola D, Launay O; French Hospital Database on HIV (FHDH-ANRS CO4 Cohort)..

Clin Infect Dis. 2015 Apr 15;60(8):1269-77. doi: 10.1093/cid/ciu1161. Epub 2015 Jan 18.

PMID:
25601456
14.

Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.

Moanna A, Rimland D.

Clin Infect Dis. 2013 Jul;57(1):122-5. doi: 10.1093/cid/cit165. Epub 2013 Mar 13.

PMID:
23487391
15.

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.

Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd, Oleske J, Williams PL; PACTG 219C Team..

Arch Pediatr Adolesc Med. 2009 Feb;163(2):164-71. doi: 10.1001/archpedi.163.2.164. Erratum in: Arch Pediatr Adolesc Med. 2009 Apr;163(4):364.

16.

The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.

Gebo KA, Kalyani R, Moore RD, Polydefkis MJ.

J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):169-74.

PMID:
16186734
17.

Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.

Gaughan DM, Mofenson LM, Hughes MD, Seage GR 3rd, Ciupak GL, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team..

Pediatrics. 2002 May;109(5):E74-4.

PMID:
11986480
18.

Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa.

Shearer K, Maskew M, Ajayi T, Berhanu R, Majuba P, Sanne I, Fox MP.

Int J Infect Dis. 2014 Jun;23:56-62. doi: 10.1016/j.ijid.2013.10.016. Epub 2014 Mar 25.

19.

Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.

Dankner WM, Lindsey JC, Levin MJ; Pediatric AIDS Clinical Trials Group Protocol Teams 051, 128, 138, 144, 152, 179, 190, 220, 240, 245, 254, 300 and 327..

Pediatr Infect Dis J. 2001 Jan;20(1):40-8.

PMID:
11176565
20.

Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children.

Nesheim SR, Hardnett F, Wheeling JT, Siberry GK, Paul ME, Emmanuel P, Bohannon B, Dominguez K; LEGACY Consortium..

Pediatr Infect Dis J. 2013 Oct;32(10):1089-95. doi: 10.1097/INF.0b013e31829ee893.

Supplemental Content

Support Center